Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Demonstration of the impact of COVID-19 on metabolic associated fatty liver disease by bioinformatics and system biology approach

1 Sept 2023

Abstract excerpt

BACKGROUND: Severe coronavirus disease 2019 (COVID-19) has caused a great threat to human health. Metabolic associated fatty liver disease (MAFLD) is a liver disease with a high prevalence rate. Previous studies indicated that MAFLD led to increased mortality and severe case rates of COVID-19 patients, but its mechanism remains unclear. METHODS: This study analyzed the transcriptional profiles of COVID-19 and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers in Disease Mechanisms
Share to COVID-19 Clinical Research Studies
Share to Liver Disease Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37657050
DOI: 10.1097/md.0000000000034570

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Demonstration of the impact of COVID-19 on metabolic associated fatty liver disease by bioinformatics and system biology approachPMID 37657050Read ↗

Genetic Predictors of Comorbid Course of COVID-19 and MAFLD: A Comprehensive AnalysisSemantic proximity Read ↗

Genetic Predictors of Comorbid Course of COVID-19 and MAFLD: A Comprehensive AnalysisSemantic proximity Read ↗

Modulatory Roles of AHR, FFAR2, FXR, and TGR5 Gene Expression in Metabolic-Associated Fatty Liver Disease and COVID-19 OutcomesSemantic proximity Read ↗

Key genes associated with non-alcoholic fatty liver disease and hepatocellular carcinoma with metabolic risk factorsSemantic proximity Read ↗

Bioinformatics and system biology approach to identify the influences of COVID-19 on metabolic unhealthy obese patientsSemantic proximity Read ↗

Modulatory Roles of AHR, FFAR2, FXR, and TGR5 Gene Expression in MAFLD and COVID-19 OutcomesSemantic proximity Read ↗

Altered Lipid Profile in COVID-19 Patients and Metabolic ReprogrammingSemantic proximity Read ↗

Comprehensive analysis of shared risk genes and immunity-metabolisms between non-alcoholic fatty liver disease and atherosclerosis via bulk and single-cell transcriptome analysesSemantic proximity Read ↗

Genetic variants associated with metabolic dysfunction-associated fatty liver diseases in a Korean populationSemantic proximity Read ↗

Genome-wide insights into the shared genetic landscape between metabolic dysfunction-associated fatty liver disease and cardiovascular diseasesSemantic proximity Read ↗

Severe liver damage, low bone mineral content, and PDXDC1/TTC39B gene variations linked to NAFLD with metabolic syndromeSemantic proximity Read ↗

Transcriptome analysis revealed FABP5 as a serum marker of metabolic associated fatty liver diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.